Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Antimicrobial Resistance

    Superbugs & Superdrugs Comes to the U.S.

    By Global Biodefense StaffJuly 7, 2016
    Superbugs & Superdrugs USA
    Share
    Facebook LinkedIn Reddit Email

    SMi Group’s respected antimicrobial event will travel to the United States this fall for the first Superbugs & Superdrugs USA on 14th and 15th November 2016.

    The program will look to address key issues surrounding funding opportunities and U.S. national plans, multi resistance gram negative infections, novel protein based biologics, antimicrobial drug development and more.

    Confirmed speakers to date include:

    • Christopher Houchens, Branch Chief, Antibacterial’s Program, BARDA
    • Rosemarie Aurigemma, Chief, Biodefense Drug Development Section, NIH
    • Anthony Simon Lynch, Senior Scientific Director, Janssen Research & Development LLC
    • Alita Miller, Director of Biology, Entasis Therapeutics
    • William J Weiss, Director, Pre-Clinical Services, UNT Health Science Center
    • Domingo Gargallo-Viola, Co-Founder and CSO, ABAC Therapeutics
    • David Cook, Chief Scientific Officer, Blueberry Therapeutics Ltd

    This decision to enter the U.S. market follows the show’s 18 years and sell-out success in Europe with an audience a quarter of the audience traveling from the States.

    For those who are interested, there is currently a $400 early bird discount available online which expires on July 15th. Further information is available at www.superbugs-usa.com.

    Global Biodefense is an official media partner of Superbugs & Superdrugs USA 2016.

    Antimicrobials ASPR BARDA Events HHS MRSA
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleCDC Releases Detailed History of Ebola Response
    Next Article Biodefense Headlines – July 10, 2016

    Related Stories

    First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test

    December 5, 2023

    Needle-Free Vaccine Patch Against Zika Virus

    December 2, 2023

    Ontario Supporting $165M Investment to Secure Critical PPE Supply

    December 2, 2023

    Inflammatix Completes Development for Acute Infection and Sepsis Test System

    November 15, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Mar 12
    Hybrid Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.